Chen Eric Sheng-Wen, Weng Jui-Hung, Chen Yu-Hou, Wang Shun-Chang, Liu Xiao-Xia, Huang Wei-Cheng, Matsui Tsutomu, Kawano Yoshiaki, Liao Jiahn-Haur, Lim Liang-Hin, Bessho Yoshitaka, Huang Kai-Fa, Wu Wen-Jin, Tsai Ming-Daw
Institute of Biological Chemistry, Academia Sinica , Taipei 115, Taiwan.
Institute of Biochemical Sciences, National Taiwan University , Taipei 106, Taiwan.
Biochemistry. 2017 Sep 26;56(38):5112-5124. doi: 10.1021/acs.biochem.7b00689. Epub 2017 Sep 15.
The vast majority of in vitro structural and functional studies of the activation mechanism of protein kinases use the kinase domain alone. Well-demonstrated effects of regulatory domains or allosteric factors are scarce for serine/threonine kinases. Here we use a site-specifically phosphorylated SCD1-FHA1-kinase three-domain construct of the serine/threonine kinase Rad53 to show the effect of phospho-priming, an in vivo regulatory mechanism, on the autophosphorylation intermediate and specificity. Unphosphorylated Rad53 is a flexible monomer in solution but is captured in an asymmetric enzyme:substrate complex in crystal with the two FHA domains separated from each other. Phospho-priming induces formation of a stable dimer via intermolecular pT-FHA binding in solution. Importantly, autophosphorylation of unprimed and phospho-primed Rad53 produced predominantly inactive pS350-Rad53 and active pT354-Rad53, respectively. The latter mechanism was also demonstrated in vivo. Our results show that, while Rad53 can display active conformations under various conditions, simulation of in vivo regulatory conditions confers functionally relevant autophosphorylation.
绝大多数关于蛋白激酶激活机制的体外结构和功能研究仅使用激酶结构域。对于丝氨酸/苏氨酸激酶,调节结构域或变构因子的明确作用尚属罕见。在此,我们使用丝氨酸/苏氨酸激酶Rad53的位点特异性磷酸化SCD1 - FHA1 - 激酶三结构域构建体,来展示磷酸化引发(一种体内调节机制)对自磷酸化中间体和特异性的影响。未磷酸化的Rad53在溶液中是一种柔性单体,但在晶体中以不对称的酶:底物复合物形式捕获,两个FHA结构域彼此分离。磷酸化引发通过溶液中的分子间pT - FHA结合诱导形成稳定的二聚体。重要的是,未引发磷酸化和引发磷酸化的Rad53的自磷酸化分别主要产生无活性的pS350 - Rad53和有活性的pT354 - Rad53。后一种机制在体内也得到了证实。我们的结果表明,虽然Rad53在各种条件下都可以呈现活性构象,但模拟体内调节条件可赋予功能相关的自磷酸化。